How to Measure Mitochondrial Health the Right Way
UCLA researchers outline best practices for respirometry, the gold-standard method for measuring cellular energy and mitochondrial function.
Summary
Measuring how much oxygen cells consume — called respirometry — has become one of the most popular ways scientists assess mitochondrial health and cellular metabolism. But inconsistent methods across labs make results hard to compare. Researchers at UCLA's David Geffen School of Medicine have published a practical guide reviewing the strengths and weaknesses of plate-based respirometry, proposing unified reporting standards, and explaining how oxygen consumption rate data should be paired with other assays for a complete picture of cellular energy use. For anyone studying aging, metabolic disease, or mitochondrial dysfunction, this matters enormously — better measurement standards mean more reliable science and faster translation into clinical insights.
Detailed Summary
Mitochondrial function sits at the center of aging biology, metabolic disease, and cellular resilience. To study it, scientists increasingly rely on respirometry — measuring how fast cells consume oxygen as a proxy for mitochondrial activity. Yet the field has lacked standardized protocols, making it difficult to compare findings across studies or institutions.
Researchers from UCLA's Department of Molecular and Medical Pharmacology published a best-practices guide in Cell Metabolism addressing this gap. The paper focuses on plate-based respirometry, the most widely adopted format, which uses instruments like the Seahorse XF Analyzer to measure oxygen consumption rate (OCR) in living cells within multi-well plates. This approach is fast, scalable, and minimally invasive, making it popular in both academic and pharmaceutical research.
The authors review the genuine strengths of OCR measurements — their sensitivity, throughput, and ability to capture real-time metabolic shifts — alongside underappreciated limitations. These include variability introduced by cell density, seeding conditions, buffer composition, and the choice of pharmacological inhibitors used to dissect specific mitochondrial pathways. Without standardized controls and reporting, results can be misleading or irreproducible.
A key contribution is the proposal of unified reporting standards: what data must be disclosed, how normalization should be performed, and which complementary assays — such as extracellular acidification rate (ECAR), ATP production assays, and substrate oxidation tests — should accompany OCR data to yield interpretable conclusions.
For longevity researchers and clinicians, this work is quietly foundational. Mitochondrial dysfunction underlies conditions from type 2 diabetes to neurodegeneration. If the measurements used to evaluate interventions targeting mitochondria are inconsistent, the entire evidence base is weakened. Standardized respirometry practices will accelerate trustworthy discoveries in metabolic health and aging.
Key Findings
- Plate-based respirometry is widely used but lacks standardized reporting protocols, limiting reproducibility across labs.
- Oxygen consumption rate (OCR) alone is insufficient; complementary assays are needed to fully characterize mitochondrial function.
- Cell density, buffer composition, and inhibitor choice are key variables that must be controlled and reported.
- The authors propose unified disclosure standards for normalization methods and experimental conditions.
- Better respirometry standards will directly improve reliability of mitochondrial research in aging and metabolic disease.
Methodology
This is a review and best-practices paper published in Cell Metabolism, not an original experimental study. The authors synthesize existing literature on plate-based respirometry and propose reporting standards based on common sources of variability and error in the field.
Study Limitations
This summary is based on the abstract only, as the full paper is behind a paywall; specific proposed standards and detailed methodology critiques cannot be fully assessed. One author (A.S.D.) has received funding from and consulted for Seahorse Bioscience, the maker of the dominant plate-based respirometry platform, which represents a potential conflict of interest.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.